T cells provide immunity against severe Covid: Study'Cellular immune response' refers to immunity through T lymphocytes or T cells that recognise specific foreign antigens and kill cells carr...
Covishield's effectiveness in fully vaccinated individuals 63% during 2nd wave: Study"More importantly, the scientists also observed that the spike-specific T-cell responses were conserved against both the delta variant and ...
Biological E seeks DCGI's nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or CovaxinCurrently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in a...
DCGI gives nod for phase 2/3 trials of Biological E's Covid vaccine on those aged between 5 & 18The phase 2 and 3 clinical trials have be conducted as per approved protocol titled 'A Prospective, Randomised, Double-blind, Placebo contr...
Mansukh Mandaviya holds meeting with Biological-E MD on progress of Covid vaccine Corbevax"Met Ms Mahima Datla, MD of @Biological_E , who briefed me on the progress of their upcoming #COVID19 vaccine, Corbevax. I assured all the ...
India destined to be global leader in science: Jitendra SinghSingh also referred to Prime Minister Narendra Modi's personal indulgence in promoting every pursuit in the field of science. The union min...
All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT Secy"(For) all our vaccines, we are looking at right now...(we) are targeting 2-8 degree because our logistics are worked out on that basis and...
There has been absolutely no compromise in clinical testing of COVID-19 vaccines: Gangandeep KangSeeking to allay apprehension of people over safety and efficacy of COVID-19 vaccines, noted clinical scientist Gagandeep Kang said that th...
First animal study in India on coronavirus moves to its final stage, says AYUSH MinistryThe clinical studies are being pursued through another collaboration of the Ministry of AYUSH, the partner in this one being the Council fo...
2nd sero survey indicates drop in infections in Mumbai slumsThe presence of COVID-19 antibodies in samples from slums in the city was found to have decreased by 12 per cent in the second sero survey,...
27 per cent Mumbai health workers have COVID-19 antibodies: SurveyAccording to the Brihanmumbai Municipal Corporation (BMC), in the first and as well as in the second round of sero-survey, approximately 27...
Scarcity of labs may slow down vaccine trialsA scarcity of laboratories equipped to handle necessary tests and meet all safety requirements may delay trials of potential Covid-19 vacci...
Indians don't need to panic yet about coronavirus, says leading researcherFour of five people who have tested positive for coronavirus will get better on their own and there is no need for Indians to panic about t...
India mulls radical change for faster vaccine availabilityHalving time for approval, sidestepping animal testing of vaccines is on the cards.
Programme launched to identify causes of premature birthsWith over 25 per cent of the total premature birth related deaths occurring in India, the Centre has launched a national programme to ident...
How to usher in vaccinnovation in IndiaThe challenge is to build on India's recent successes in vaccine research to reach the global cutting edge in producing vaccines for killer...
- Hi-tech lab in Gurgaon to design vaccine for HIV
Gurgaon will now be home to the country’s first state-ofthe-art laboratory that will exclusively work to design an effective vaccine agains...